copper sulfate has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Fukuda, N; Higuchi, T; Matsukawa, Y; Matsumoto, K; Ohnishi, Y; Oikawa, O; Okada, K; Soma, M; Yamazaki, T | 1 |
| Azadmanesh, K; Hedayati, MH; Hosseini, SN; Kaghazian, H; Mahdian, R; Mortazavi, M; Sardari, S; Shokrgozar, MA | 1 |
2 other study(ies) available for copper sulfate and losartan potassium
| Article | Year |
|---|---|
Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia.
Topics: Anemia; Ceruloplasmin; Copper; Copper Sulfate; Deficiency Diseases; Enteral Nutrition; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Middle Aged; Neutropenia; Recombinant Proteins; Renal Dialysis; Treatment Failure | 2006 |
Using chemical chaperones to increase recombinant human erythropoietin secretion in CHO cell line.
Topics: Animals; Apoptosis; beta-Alanine; Carbohydrates; Cell Proliferation; CHO Cells; Copper Sulfate; Cricetulus; Cysteine; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Erythropoietin; Gene Expression; Humans; Linoleic Acids; Molecular Chaperones; Organic Chemicals; Recombinant Proteins | 2019 |